Funding of drug treatment of multiple sclerosis should not be delayed. [electronic resource]
- BMJ (Clinical research ed.) Nov 1997
- 1160-1 p. digital
Publication Type: Comment; Letter
0959-8138
10.1136/bmj.315.7116.1160b doi
Adjuvants, Immunologic--economics Capital Financing Clinical Trials as Topic Decision Making Humans Interferon-beta--economics Multiple Sclerosis--drug therapy